TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.2, pp.644-652, 2019 (SCI-Expanded)
Background/aim: The main purpose of our study was to determine the efficacy of chemical shift imaging (CSI) for differentiating diffuse red bone marrow reconversion (RBMR) and hematological malignancies. We also aimed to calculate the cut-off value for these entities with similar imaging features in routine magnetic resonance (MR) sequences.